Drug Shortage Report for PMS-NAPROXEN
Report ID | 6142 |
Drug Identification Number | 02017237 |
Brand name | PMS-NAPROXEN |
Common or Proper name | NAPROXEN |
Company Name | PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | NAPROXEN |
Strength(s) | 500MG |
Dosage form(s) | SUPPOSITORY |
Route of administration | RECTAL |
Packaging size | 30 |
ATC code | M01AE |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-04-12 |
Estimated end date | Unknown |
Actual end date | 2020-06-09 |
Shortage status | Resolved |
Updated date | 2020-06-10 |
Company comments | Product to be discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-06-10 | French | Compare |
v6 | 2020-06-10 | English | Compare |
v5 | 2017-05-12 | French | Compare |
v4 | 2017-05-12 | English | Compare |
v3 | 2017-04-13 | English | Compare |
v2 | 2017-04-07 | French | Compare |
v1 | 2017-04-07 | English | Compare |
Showing 1 to 7 of 7